Severe combined immunodeficiency mouse-human skin chimeras: A unique animal model for the study of psoriasis and cutaneous inflammation

British Journal of Dermatology

Volumn 144, Issue 5, 2001, Pages 931-939

  Ahmed, I ^a   Agarwal, S ^a   Ilchyshyn, A ^a   Charles Holmes, S ^b   Berth Jones, J ^a  

^a UNIVERSITY HOSPITALS COVENTRY AND WARWICKSHIRE NHS TRUST   (United Kingdom)

^b GEORGE ELIOT HOSPITAL   (United Kingdom)

Author keywords

Inflammation; Mouse human skin chimera; Psoriasis; SCID mouse

Indexed keywords

CHEMOKINE; CYTOKINE;

ANGIOGENESIS; CELL PROLIFERATION; CHIMERA; NEUROGENIC INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; PSORIASIS; REVIEW; SCID MOUSE; SKIN; SKIN INFLAMMATION; T LYMPHOCYTE; TARGET ORGAN; TRANSPLANTATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; DERMATITIS; DISEASE MODELS, ANIMAL; HUMANS; MICE; MICE, SCID; PSORIASIS; TRANSPLANTATION CHIMERA; TRANSPLANTATION, HETEROLOGOUS;

EID: 0035724421     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2001.04178.x     Document Type: Review

References (74)

1. Inherited mouse mutations as models of human adnexal, cornification, and papulosquamous dermatoses
2. Skin lipids of a normal and mutant (asebic) mouse strain
3. The flaky skin (fsn) mutation chromosome?
4. Inflammatory skin disease in transgenic mice that express high levels of interleukin 1 alpha in basal epidermis
5. Transgenic mice expressing IFN-gamma in the epidermis have eczema, hair hypopigmentation, and hair loss
6. Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice
7. A polygenic mouse model of psoriasiform skin disease in CD18-deficient mice
8. Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human beta 2m: An animal model of HLA-B27-associated human disorders
9. Involved and uninvolved skin from psoriatic subjects: Are they equally diseased? Assessment by skin transplanted to congenitally athymic (nude) mice
10. Severe combined immunodeficiency mouse and human psoriatic skin chimeras - Validation of a new model
11. Normal and psoriatic human skin grafts on 'nude' mice: Morphological and immunohistochemical studies
12. Rearrangement of antigen receptor genes is defective in severe combined immunodeficiency
13. The scid mutation in mice causes a general defect in DNA repair
14. V(D)J recombination: Broken DNA molecules with covalently sealed (hairpin) coding ends in scid mouse thymocytes
15. The SCID mouse mutant: Definition, characterization, and potential use
16. Transfer of a functional human system to mice with severe combined immunodeficiency
17. The SCID-hu mouse: Murine model for the analysis of human hematolymphoid differentiation and function
18. The Scid mouse: Relevance as an animal model system for studying human disease
19. T lymphocyte dependence of psoriatic pathology in human psoriatic skin grafted to SCID mouse
20. Histological and immunochemical studies of human psoriatic lesions transplanted onto SCID mice
21. Dermal injection of immunocytes induces psoriasis
22. Injection of pre-psoriatic skin with CD4+ T cells induces psoriasis
23. Induction of psoriasiform inflammation by a bacterial superantigen in the SCID-hu xenogeneic transplantation model
24. Anti-CD4 monoclonal antibody therapy in severe psoriasis
25. Response of psoriasis to a lymphocyte selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis
26. Is psoriasis a neuroimmunologic disease?
27. Murine psoriasis-like disorder induced by naive CD4+ cells
28. IL-12 independently of IFN-gamma, plays a crucial role in the pathogenesis of a murine psoriasis-like skin disorder
29. The immunologic and genetic basis of psoriasis
30. Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha in rheumatoid arthritis
31. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein
32. Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist
33. Reversion of psoriatic lesions with monoclonal-CD3 (orthoclone OKT3) treatment
34. Inducibility and expression of microvascular endothelial adhesion molecules in lesional, perilesional, and uninvolved skin of psoriatic patients
35. Endothelial cell adhesion molecules in psoriasis
36. The development of manifest psoriatic lesions is linked with the appearance of ICAM-1 positivity on keratinocytes
37. Skin-infiltrating lymphocytes in normal and disordered skin: Activation signals and functional roles in psoriasis and mycosis fungoides-type cutaneous T cell lymphoma
38. Differential expression of ICAM-1, E-selectin and VCAM-1 by endothelial cells in psoriasis and contact dermatitis
39. Quantification of microvascular changes in the skin in patients with psoriasis
40. Levels of endothelial cell stimulating angiogenesis factor and vascular endothelial growth factor are elevated in psoriasis
41. Immunocompetent cells in psoriasis
42. The development of manifest psoriatic lesions is linked with the invasion of CD8+ T cells and CD11c+ macrophages into the epidermis
43. Mast cells of psoriatic and atopic dermatitis skin are positive for TNF-alpha and their degranulation is associated with expression of ICAM-1 in the epidermis
44. Mast cells tryptase and chymase in developing and mature psoriatic lesions
45. Neutrophil-activating proteins in psoriasis
46. Co-localized overexpression of GRO-α and IL-8 mRNA is restricted to the suprapapillary layers of psoriatic lesions
47. Identification of high levels of RANTES in the psoriatic keratinocytes
48. Role of fractalkine in cutaneous disease
49. Quantification of cutaneous sensory nerves and their substance P content in psoriasis
50. Neurogenic changes in psoriasis. An immunohistochemical study
51. Occurrence and distribution of neuropeptides in human skin. An immunocytochemical and immunohistochemical study on normal skin and blister fluid from inflamed skin
52. Double labeled immunofluorescence study of cutaneous nerves in psoriasis
53. Stress, symmetry and psoriasis: Possible role of neuropeptides
54. Effects of topically applied capsaicin on moderate and severe psoriasis vulgaris
55. Treatment of psoriasis with chronic subcutaneous administration of somatostatin analog 201-295 (Sandostatin). An open label pilot study
56. Peptide T improves psoriasis when infused into lesions in nanogram amounts
57. Peptide T in treatment of AIDS
58. Are sensory nerves essential for the development of psoriasis lesion?
59. Expression of the NGF receptor gene in sensory neurons and their cutaneous targets prior to and during innervation
60. Nerve growth factor regulates expression of neuropeptides genes in adult sensory neurons
61. Effect of exposure to anti-NGF on sensory neurons of adult rats and guinea pigs
62. Psoriatic keratinocytes express high levels of nerve growth factor
63. Increased nerve growth factor receptor (NGF-R) in papillary dermis of lesional psoriatic skin: Further evidence for a role of the sensory nervous systems in the pathogenesis of psoriasis
64. Nerve growth factor is increased in psoriatic skin
65. Density and fine structure of peripheral nerves in various skin lesions of atopic dermatitis
66. Evidence for neural regulation of inflammatory synovial cell functions by secreting calcitonin gene-related peptide and vasoactive intestinal peptide in patients with rheumatoid arthritis
67. Stress and mind-body impact on the course of inflammatory bowel diseases
68. Airway sensory nerves: A burning issue in asthma?
69. Capsaicin and sensory neurons: A review
70. Substance P and related peptides: Cellular and molecular physiology
71. A potent nonpeptide antagonist of the substance P (NK-1) receptor
72. Reduction of leaky lymphocyte clones producing immunoglobulin and thymic lymphocytic leukemia by selective inbreeding of SCID (severe combined immunodeficiency) mice
73. Homozygous scid/scid; beige/ beige mice have low levels of spontaneous or neonatal T cell induced B cell generation
74. Strain dependent leakiness of mice with severe combined immune deficiency